Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men

Conditions:   Gonorrhea;   Chlamydia;   Syphilis Intervention:   Drug: Doxycycline Hyclate Delayed-Release 200 mg Sponsors:   University of California, San Francisco;   University of Washington;   National Institute of Allergy and Infectious Diseases (NIAID);   Mayne Pharma International Pty Ltd;   San Francisco Department of Public Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials